Corporate Information

For Patient Well-being Around the World — Advancing New and Innovative Treatment Options

Otsuka Medical Devices was founded in 2011 with a bold vision: to establish our medical device business as one of the Otsuka group’s core pillars supporting the total healthcare mission of the group — contributing to people’s health worldwide. We are now transitioning from the research and development phase to a commercialization phase, where we manufacture and distribute our products globally.

With an aging population and changing lifestyles, an ever-increasing number of patients require treatment options beyond pharmaceutical therapies alone. We are committed to pioneering innovative medical devices that provide new treatment options through a physical, device-based approach, distinct from pharmaceuticals. Furthermore, we prioritize improving patients' quality of life by developing devices that minimize physical burden and support their well-being.

In November 2023, our novel therapy, Paradise™ Ultrasound Renal Denervation system, received FDA approval as an adjunctive treatment option for the treatment of hypertension when lifestyle changes and medications have not adequately controlled a patient’s blood pressure. In the U.S., insurance coverage has been gradually expanding, allowing more patients access to this therapy. In August 2025, the therapy received approval for manufacturing and marketing for the treatment of resistant hypertension from Japan’s Ministry of Health, Labour, and Welfare, followed by reimbursement effective March 1, 2026. As we mark these important milestones, we are pleased to offer a new treatment option to patients with resistant hypertension in Japan, to support their journey toward a healthier future.

At the heart of our efforts is a strong desire to help as many patients as possible regain their health and lead more fulfilling daily lives by providing new treatment options. To bring this commitment to life, we are also focusing on developing innovative treatment approaches that leverage advanced digital technologies and foster collaboration across the Otsuka group.


As a proud member of the Otsuka group, a leading total healthcare company, we reaffirm our commitment to contributing to the well-being of people worldwide.


President and Representative Director
Otsuka Medical Devices Co., Ltd.